Marex Group plc

Position in GILD — Gilead Sciences, Inc.

CIK 1997464 London, X0

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$317,744

-$632,898 QoQ

Shares Held

2,515

-63.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,617

of 2,266 holders

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Marex Group plc holds $405,541,812 across 9 Drug Manufacturers - General names. GILD ranks #9 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	249,397	$299,134,267
2	AMGN	Amgen Inc	197,671	$71,580,622
3	NVO	Novo Nordisk A S	518,286	$24,846,630
4	PFE	Pfizer Inc	178,990	$4,310,079
5	MRK	Merck & Co., Inc.	13,315	$1,710,977
6	JNJ	Johnson & Johnson	5,784	$1,468,962
7	ABBV	AbbVie Inc.	5,599	$1,408,932
8	AZN	Astrazeneca PLC	4,027	$763,599

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$317,744	2,515	-63.1%	Shares	Defined	2026-08-14
2026-03-31	$950,642	6,821	+19.4%	Shares	Defined	2026-05-13
2025-12-31	$700,967	5,711	+15.2%	Shares	Defined	2026-02-12
2025-09-30	$550,116	4,956	+137.6%	Shares	Defined	2025-11-14
2025-03-31	$233,736	2,086	-30.2%	Shares	Defined	2026-04-02
2024-09-30	$250,513	2,988	-40.3%	Shares	Defined	2026-04-07
2024-06-30	$343,598	5,008	+22.2%	Shares	Defined	2026-04-02
2024-03-31	$300,105	4,097	-98.7%	Shares	Defined	2026-04-02
2023-12-31	$26,144,519	322,732	+822.1%	Shares	Defined	2026-04-02
2023-06-30	$2,697,450	35,000	+393.0%	Shares	Defined	2026-04-02
2022-12-31	$609,535	7,100	—	Shares	Defined	2026-04-02
No filing history on record for this holder in this stock.